Authored by: Nancy Dreyer, MPH, Ph.D., Global Chief of Scientific Affairs and Michelle Leavy, MPH, Manager, Health Policy, Quintiles
Published in: BioScience Technology – 28th October 2015
Industry thought-leader Nancy Dreyer reviews the latest thinking in pharmacovigilance and the promise of direct-to-patient registries. Nancy outlines Quintiles’ involvement in the PROTECT (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) study and highlights that “with the rapid advance of technology, we have seen a number of non-traditional approaches to AE reporting cropping up… the web-based solution offered by MyMeds&Me offers an intuitive, standardized method of capturing AE data via SaaS. Patients can simply point and click on “where it hurts” to generate direct-from-patient data nearly instantly.”
